Genoway SA
PAR:ALGEN

Watchlist Manager

Genoway SA

PAR:ALGEN

Watchlist

Dividends

Discount Rate

Price: 3.48 EUR Market Closed

Market Cap: 31.4m EUR

Have any thoughts about
Genoway SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 3.48 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

ALGEN Alert

Genoway SA

3.48

0.00 (0%)

52 Week Range	3.36 4.8
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Genoway SA

What unique competitive advantages
does Genoway SA hold over its rivals?

What risks and challenges
does Genoway SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Genoway SA.

What unique competitive advantages
does Genoway SA hold over its rivals?

What risks and challenges
does Genoway SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Genoway SA.

Provide P/S
for Genoway SA.

Provide P/E
for Genoway SA.

Provide P/OCF
for Genoway SA.

Provide P/FCFE
for Genoway SA.

Provide P/B
for Genoway SA.

Provide EV/S
for Genoway SA.

Provide EV/GP
for Genoway SA.

Provide EV/EBITDA
for Genoway SA.

Provide EV/EBIT
for Genoway SA.

Provide EV/OCF
for Genoway SA.

Provide EV/FCFF
for Genoway SA.

Provide EV/IC
for Genoway SA.

Show me price targets
for Genoway SA made by professional analysts.

What are the Revenue projections
for Genoway SA?

How accurate were the past Revenue estimates
for Genoway SA?

What are the Net Income projections
for Genoway SA?

How accurate were the past Net Income estimates
for Genoway SA?

What are the EPS projections
for Genoway SA?

How accurate were the past EPS estimates
for Genoway SA?

What are the EBIT projections
for Genoway SA?

How accurate were the past EBIT estimates
for Genoway SA?

Compare the revenue forecasts
for Genoway SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Genoway SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Genoway SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Genoway SA compared to its peers.

Compare the P/E ratios
of Genoway SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Genoway SA with its peers.

Analyze the financial leverage
of Genoway SA compared to its main competitors.

Show all profitability ratios
for Genoway SA.

Provide ROE
for Genoway SA.

Provide ROA
for Genoway SA.

Provide ROIC
for Genoway SA.

Provide ROCE
for Genoway SA.

Provide Gross Margin
for Genoway SA.

Provide Operating Margin
for Genoway SA.

Provide Net Margin
for Genoway SA.

Provide FCF Margin
for Genoway SA.

Show all solvency ratios
for Genoway SA.

Provide D/E Ratio
for Genoway SA.

Provide D/A Ratio
for Genoway SA.

Provide Interest Coverage Ratio
for Genoway SA.

Provide Altman Z-Score Ratio
for Genoway SA.

Provide Quick Ratio
for Genoway SA.

Provide Current Ratio
for Genoway SA.

Provide Cash Ratio
for Genoway SA.

What is the historical Revenue growth
over the last 5 years for Genoway SA?

What is the historical Net Income growth
over the last 5 years for Genoway SA?

What is the current Free Cash Flow
of Genoway SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Genoway SA.

P/E
Price to Earnings

19.5

Current

22.5

Median

Industry

Lower than median

Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E

19.5

Market Cap

30.6m EUR

Net Income

1.6m EUR

All Countries

Forward Multiples

			Market Cap	P/E
FR		Genoway SA PAR:ALGEN	30.6m EUR	19.5
FR		Pharnext SCA OTC:PNEXF	6T USD	-178 533.6
US		Abbvie Inc NYSE:ABBV	301B USD	59.2
US		Amgen Inc NASDAQ:AMGN	162B USD	38.3
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	127.5B USD	-265.7
US		Gilead Sciences Inc NASDAQ:GILD	115.4B USD	916
US	E	Epizyme Inc F:EPE	94.1B EUR	-478.6
AU		CSL Ltd ASX:CSL	138B AUD	33.9
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	88.6B USD	19
US	S	Seagen Inc F:SGT	39.3B EUR	-55.4
NL		argenx SE XBRU:ARGX	34.1B EUR	-129.9

				Earnings Growth
FR		Genoway SA PAR:ALGEN	Average P/E: 181 19.5	-41%
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -178 533.6	N/A
US		Abbvie Inc NYSE:ABBV	59.2	412%
US		Amgen Inc NASDAQ:AMGN	38.3	73%
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	Negative Multiple: -265.7	42%
US		Gilead Sciences Inc NASDAQ:GILD	916	75%
US	E	Epizyme Inc F:EPE	Negative Multiple: -478.6	N/A
AU		CSL Ltd ASX:CSL	33.9	65%
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	19	43%
US	S	Seagen Inc F:SGT	Negative Multiple: -55.4	N/A
NL		argenx SE XBRU:ARGX	Negative Multiple: -129.9	N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/E

32.9

2-Years Forward

P/E

32.9

3-Years Forward

P/E

32.9

Genoway SA
PAR:ALGEN

P/E
Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Genoway SA PAR:ALGEN

P/E Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Genoway SA
PAR:ALGEN

P/E
Price to Earnings